Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

UBS
QuintilesIMS
Harvard Business School
Baxter
Express Scripts
Mallinckrodt

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 8,900,582

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,900,582
Title:Deimmunized anti c-Met humanized antibodies and uses thereof
Abstract: A deimmunized anti c-Met humanized antibody and a pharmaceutical composition including the same, and method for the prevention and treatment of cancer.
Inventor(s): Cheong; Kwang-ho (Seoul, KR), Lee; Seung-hyun (Suwon-si, KR)
Assignee: Samsung Electronics Co., Ltd. (Suwon-Si, KR)
Application Number:13/725,125
Patent Claims:see list of patent claims

Details for Patent 8,900,582

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Try a Free Trial Samsung Electronics Co., Ltd. (Suwon-Si, KR) 2031-12-22 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Deloitte
US Army
Healthtrust
Julphar
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.